These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7972856)

  • 1. Interaction of central and peripheral benzodiazepine sites in benzodiazepine tolerance and discontinuation.
    Miller LG; Koff JM
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Sep; 18(5):847-57. PubMed ID: 7972856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic benzodiazepine administration. X. Concurrent administration of the peripheral-type benzodiazepine ligand PK11195 attenuates chronic effects of lorazepam.
    Miller LG; Galpern WR; Byrnes JJ; Greenblatt DJ; Shader RI
    J Pharmacol Exp Ther; 1992 Apr; 261(1):285-9. PubMed ID: 1313872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of lorazepam tolerance and withdrawal on GABAA receptor operated chloride channels in mice selected for differences in ethanol withdrawal severity.
    Allan AM; Baier LD; Zhang X
    Life Sci; 1992; 51(12):931-43. PubMed ID: 1381457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic benzodiazepine administration. XI. Concurrent administration of PK11195 attenuates lorazepam discontinuation effects.
    Byrnes JJ; Miller LG; Perkins K; Greenblatt DJ; Shader RI
    Neuropsychopharmacology; 1993 May; 8(3):267-73. PubMed ID: 8389555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic benzodiazepine administration: from the patient to the gene.
    Miller LG
    J Clin Pharmacol; 1991 Jun; 31(6):492-5. PubMed ID: 1652596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NMDA receptor competitive antagonist CPP modulates benzodiazepine tolerance and discontinuation.
    Koff JM; Pritchard GA; Greenblatt DJ; Miller LG
    Pharmacology; 1997 Nov; 55(5):217-27. PubMed ID: 9399331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant-like effect of Ro5-4864, a peripheral-type benzodiazepine receptor ligand, in forced swimming test.
    Gavioli EC; Duarte FS; Bressan E; Ferrara P; Farges RC; De Lima TC
    Eur J Pharmacol; 2003 Jun; 471(1):21-6. PubMed ID: 12809948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-aryl-imidazo[2,1-c][1,4]benzodiazepine derivatives as tricyclic constrained analogues of diazepam and Ro5-4864. Synthesis and binding properties at peripheral and central benzodiazepine receptors.
    Rizzetto E; Castellano S; Florio C; Vadori M; Stefancich G
    Pharmazie; 2006 Jun; 61(6):505-10. PubMed ID: 16826968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic benzodiazepine administration. XII. Anticonvulsant cross-tolerance but distinct neurochemical effects of alprazolam and lorazepam.
    Byrnes JJ; Miller LG; Greenblatt DJ; Shader RI
    Psychopharmacology (Berl); 1993; 111(1):91-5. PubMed ID: 7870939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic benzodiazepine administration. II. Discontinuation syndrome is associated with upregulation of gamma-aminobutyric acidA receptor complex binding and function.
    Miller LG; Greenblatt DJ; Roy RB; Summer WR; Shader RI
    J Pharmacol Exp Ther; 1988 Jul; 246(1):177-82. PubMed ID: 2455789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of binding sites for the omega3 receptor ligands [3H]PK11195 and [3H]RO5-4864 in human brain.
    Rao VL; Butterworth RF
    Eur J Pharmacol; 1997 Dec; 340(1):89-99. PubMed ID: 9527511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzodiazepine agonist and inverse agonist actions on GABAA receptor-operated chloride channels. II. Chronic effects of ethanol.
    Buck KJ; Harris RA
    J Pharmacol Exp Ther; 1990 May; 253(2):713-9. PubMed ID: 2160008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic benzodiazepine administration. IV. Rapid development of tolerance and receptor downregulation associated with alprazolam administration.
    Miller LG; Woolverton S; Greenblatt DJ; Lopez F; Roy RB; Shader RI
    Biochem Pharmacol; 1989 Nov; 38(21):3773-7. PubMed ID: 2557030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in benzodiazepine-receptor activity modify morphine withdrawal syndrome in mice.
    Valverde O; Micó JA; Maldonado R; Gibert-Rahola J
    Drug Alcohol Depend; 1992 Aug; 30(3):293-300. PubMed ID: 1327709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of chronic lorazepam and alprazolam on benzodiazepine binding and GABAA-receptor function.
    Galpern WR; Miller LG; Greenblatt DJ; Shader RI
    Br J Pharmacol; 1990 Dec; 101(4):839-42. PubMed ID: 1964820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspects of benzodiazepine receptor structure and function with relevance to drug tolerance and dependence.
    Schoch P; Moreau JL; Martin JR; Haefely WE
    Biochem Soc Symp; 1993; 59():121-34. PubMed ID: 7910739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic administration of benzodiazepines--V. Rapid onset of behavioral and neurochemical alterations after discontinuation of alprazolam.
    Lopez F; Miller LG; Greenblatt DJ; Chesley S; Schatzki A; Shader RI
    Neuropharmacology; 1990 Mar; 29(3):237-41. PubMed ID: 1691458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic benzodiazepine administration. VI. A partial agonist produces behavioral effects without tolerance or receptor alterations.
    Miller LG; Galpern WR; Greenblatt DJ; Lumpkin M; Shader RI
    J Pharmacol Exp Ther; 1990 Jul; 254(1):33-8. PubMed ID: 2164100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effects of drug administration and withdrawal on the benzodiazepine receptor.
    Scharf MB; Feil P
    Life Sci; 1983 Apr; 32(15):1771-7. PubMed ID: 6300599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitrendipine decreases benzodiazepine withdrawal seizures but not the development of benzodiazepine tolerance or withdrawal signs.
    Dolin SJ; Patch TL; Rabbani M; Siarey RJ; Bowhay AR; Little HJ
    Br J Pharmacol; 1990 Nov; 101(3):691-7. PubMed ID: 1963805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.